Medicare Enrolled
Dr. Thomas Dunlap, M.D.
Interventional Cardiology · Santa Rosa, CA
Practice pattern: Remote Monitoring
— Significant remote device monitoring activity
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dunlap from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dunlap?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dunlap
Dr. Thomas Dunlap is an interventional cardiology specialist in Santa Rosa, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dunlap performed 7,215 Medicare services across 2,723 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dunlap received a total of $6,268 from 33 pharmaceutical and/or device companies across 251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dunlap is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in CA
$6,268 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,215
Medicare services
Top 15% in CA for interventional cardiology
2,723
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~361 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Outpatient cardiac rehabilitation with ECG monitoring Supervised heart rehabilitation program including electrocardiogram monitoring and professional healthcare services. |
3,320 | $22 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
820 | $96 | $342 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
654 | $144 | $485 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
399 | $166 | $565 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
367 | $23 | $79 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
259 | $12 | $39 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
240 | $156 | $573 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
214 | $20 | $69 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
145 | $124 | $175 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
144 | $57 | $240 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
124 | $20 | $69 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
116 | $28 | $98 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
110 | $96 | $345 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
57 | $34 | $157 |
| New patient office visit, complex (60-74 min) | 49 | $170 | $591 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
40 | $43 | $194 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
34 | $81 | $302 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
31 | $19 | $70 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
31 | $18 | $65 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
26 | $68 | $280 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
23 | $10 | $41 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
12 | $10 | $145 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.6% high complexity
3.3% medium
81.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,268
Total received (2018-2024)
Avg $895/year across 7 years
Bottom 49% in CA for interventional cardiology
33
Companies
251
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,244 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,128
2023
$874
2022
$868
2021
$1,137
2020
$570
2019
$905
2018
$786
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$394
Amgen Inc.
$201
Novartis Pharmaceuticals Corporation
$150
E.R. Squibb & Sons, L.L.C.
$138
Esperion Therapeutics, Inc.
$68
Abbott Laboratories
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$35
AstraZeneca Pharmaceuticals LP
$32
Boston Scientific Corporation
$32
Novo Nordisk Inc
$25
PFIZER INC.
$15
Top 3 companies account for 66.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,100
Novartis Pharmaceuticals Corporation
$662
Abbott Laboratories
$598
Medtronic Vascular, Inc.
$529
E.R. Squibb & Sons, L.L.C.
$518
Edwards Lifesciences Corporation
$471
Esperion Therapeutics, Inc.
$345
Medtronic, Inc.
$271
AstraZeneca Pharmaceuticals LP
$219
Boston Scientific Corporation
$152
Boehringer Ingelheim Pharmaceuticals, Inc.
$143
AngioDynamics, Inc.
$142
Bayer HealthCare Pharmaceuticals Inc.
$133
Regeneron Healthcare Solutions, Inc.
$118
Actelion Pharmaceuticals US, Inc.
$106
Kowa Pharmaceuticals America, Inc.
$94
Janssen Pharmaceuticals, Inc
$87
Impulse Dynamics (USA) Inc.
$66
SANOFI-AVENTIS U.S. LLC
$64
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$62
Braemar Manufacturing, LLC
$61
Novo Nordisk Inc
$43
ABIOMED
$43
Gilead Sciences, Inc.
$40
United Therapeutics Corporation
$38
PFIZER INC.
$32
Bardy Diagnostics, Inc.
$30
Amarin Pharma Inc.
$22
Philips Electronics North America Corporation
$21
PORTOLA PHARMACEUTICALS, INC.
$17
Preventice Services, LLC
$15
CVRx, Inc.
$13
iRhythm Technologies, Inc.
$13
Top 3 companies account for 37.6% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · ASSURITY · Adempas · Azure · BEVYXXA · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · Cardiac Monitoring Suite · CardioMEMS HF System · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · General - Therapies · IN.PACT Admiral · Impella · JARDIANCE · Kerendia · LEQVIO · LINQ II · LifeVest · Livalo · MITRIS RESILIA Mitral Valve · Micra · Mitra Clip system · MitraClip System · MyCareLink · NEXLETOL · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · ORENITRAM · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Reveal LINQ · Rybelsus · SAPIEN 3 Ultra RESILIA · UPTRAVI · VENASEAL · VYNDAQEL · Vascepa · VenaSeal · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
2
Per 100K population
0.4
County median income
$102,840
Nearest hospital
SUTTER SANTA ROSA REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dunlap is a remote monitoring specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dunlap experienced with outpatient cardiac rehabilitation with ecg monitoring?
Based on Medicare claims data, Dr. Dunlap performed 3,320 outpatient cardiac rehabilitation with ecg monitoring services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dunlap receive payments from pharmaceutical companies?
Yes. Dr. Dunlap received a total of $6,268 from 33 companies across 251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dunlap's costs compare to other interventional cardiologists in Santa Rosa?
Dr. Dunlap's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dunlap) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Santa Rosa
Browse interventional cardiologists in Santa Rosa ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology